SYK and retinoblastoma: The same study also demonstrated that the expression of spleen tyrosine kinase (Syk) is increased by epigenetic changes in retinoblastomas and is required for the survival of retinoblastoma cells, making Syk a potential therapeutic target (Zhang et al. 2012).